Epitinib succinate

CAS No. 2252334-12-4

Epitinib succinate( —— )

Catalog No. M28061 CAS No. 2252334-12-4

Epitinib succinate is an orally active and selective epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) designed for optimal brain penetration. Epitinib succinate can be used for the research of cancer.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 93 In Stock
5MG 164 In Stock
10MG 272 In Stock
25MG 449 In Stock
50MG 603 In Stock
100MG 826 In Stock
200MG Get Quote In Stock
500MG 1655 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Epitinib succinate
  • Note
    Research use only, not for human use.
  • Brief Description
    Epitinib succinate is an orally active and selective epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) designed for optimal brain penetration. Epitinib succinate can be used for the research of cancer.
  • Description
    Epitinib succinate is an orally active and selective epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) designed for optimal brain penetration. Epitinib succinate can be used for the research of cancer.
  • In Vitro
    Epitinib succinate is an orally active and selective epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) designed for optimal brain penetration.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    lysosomal acid lipase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2252334-12-4
  • Formula Weight
    548.59
  • Molecular Formula
    C28H32N6O6
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 12.5 mg/mL (22.79 mM)
  • SMILES
    N/A
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Rosenbaum et al (2009) Chemical screen to reduce sterol accumulation in Niemann-Pick C disease cells identifies novel lysosomal acid lipase inhibitors. Biochim.Biophys.Acta. 1791 1155
molnova catalog
related products
  • 5-A-RU-PABC-Val-Cit-...

    5-A-RU-PABC-Val-Cit-Fmoc is a precursor of 5-A-RU, a small molecule activator associated with mucosal-associated invariant T (MAIT) cells and a precursor in bacterial riboflavin synthesis.

  • C. difficile Toxin B...

    C. difficile Toxin B (8 - 16)

  • Syntide 2 (TFA)

    Syntide 2 (TFA) is a Ca2+ and CaM dependent protein kinase II (CaMKII) substrate peptide that selectively inhibits the gibberellin (GA) response, leaving composition and slicoic acid regulatory events unaffected.